Clinical trial
Survivin Urine mRNA Assay Risk of Bladder Cancer Study
NCT00315653 · Fujirebio Diagnostics, Inc., Industry · Completed
Key facts
| NCT number | NCT00315653 |
|---|---|
| Title | Survivin Urine mRNA Assay Risk of Bladder Cancer Study |
| Official title | Evaluation of the Survivin Urine mRNA Assay to Estimate Risk of Bladder Cancer Found on Cystoscopy |
| Lead sponsor | Fujirebio Diagnostics, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Bladder Cancer |
| Enrollment | 600 |
| Start date | Sep 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Apr 19, 2006 |
| Last update posted | Mar 14, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: